Mining databases for protein aggregation: a review

References

• Aguzzi A, O'Connor T. Protein aggregation diseases: pathogenicity and therapeutic perspectives. Nat Rev Drug Discov. 2010;9:237–248.
   PubMed Web of Science ®Google Scholar
• Eisele YS, Monteiro C, Fearns C, et al. Targeting protein aggregation for the treatment of degenerative diseases. Nat Rev Drug Discov. 2015;14:759–780.
   PubMed Web of Science ®Google Scholar
• Frokjaer S, Otzen DE. Protein drug stability: a formulation challenge. Nat Rev Drug Discov. 2005;4:298–306.
   PubMed Web of Science ®Google Scholar
• Mitraki A. Protein aggregation from inclusion bodies to amyloid and biomaterials. Adv Protein Chem Struct Biol. 2010;79:89–125.
   PubMed Web of Science ®Google Scholar
• Cherny I, Gazit E. Amyloids: not only pathological agents but also ordered nanomaterials. Angew Chem Int Ed Engl. 2008;47:4062–4069.
   PubMed Web of Science ®Google Scholar
• Sipe JD, Benson MD, Buxbaum JN, et al. Nomenclature 2014: amyloid fibril proteins and clinical classification of the amyloidosis. Amyloid. 2014;21:221–224.
   PubMed Web of Science ®Google Scholar
• Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci. 2003;4:49–60.
   PubMed Web of Science ®Google Scholar
• Sipe JD, Benson MD, Buxbaum JN, et al. Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines. Amyloid. 2016;23:209–213.
   PubMed Web of Science ®Google Scholar
• Ross CA, Poirier MA. Opinion: what is the role of protein aggregation in neurodegeneration? Nat Rev Mol Cell Biol. 2005;6:891–898.
   PubMed Web of Science ®Google Scholar
• Agrawal NJ, Kumar S, Wang X, et al. Aggregation in protein-based biotherapeutics: computational studies and tools to identify aggregation-prone regions. J Pharm Sci. 2011;100:5081–5095.
   PubMed Web of Science ®Google Scholar
• Fandrich M. Structure and formation of amyloid fibrils. Acta Histochem. 2003;105:379.
   PubMed Web of Science ®Google Scholar
• Hammer ND, Wang X, McGuffie BA, et al. Amyloids: friend or foe? J Alzheimers Dis. 2008;13:407–419.
   PubMed Web of Science ®Google Scholar
• Iconomidou VA, Vriend G, Hamodrakas SJ. Amyloids protect the silkmoth oocyte and embryo. FEBS Lett. 2000;479:141–145.
   PubMed Web of Science ®Google Scholar
• Iconomidou VA, Chryssikos GD, Gionis V, et al. Amyloid-like fibrils from an 18-residue peptide analogue of a part of the central domain of the B-family of silkmoth chorion proteins. FEBS Lett. 2001;499:268–273.
   PubMed Web of Science ®Google Scholar
• Fandrich M. On the structural definition of amyloid fibrils and other polypeptide aggregates. Cell Mol Life Sci. 2007;64:2066–2078.
   PubMed Web of Science ®Google Scholar
• Sunde M, Blake C. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv Protein Chem. 1997;50:123–159.
   PubMedGoogle Scholar
• Geddes AJ, Parker KD, Atkins ED, et al. “Cross-beta” conformation in proteins. J Mol Biol. 1968;32:343–358.
   PubMed Web of Science ®Google Scholar
• Eichner T, Radford SE. A diversity of assembly mechanisms of a generic amyloid fold. Mol Cell. 2011;43:8–18.
   PubMed Web of Science ®Google Scholar
• Ashkenazi Y, Hersko C, Gafni J, et al. Chemical aspects of amyloid-Congo red binding. Isr J Med Sci. 1967;3:572–574.
   PubMedGoogle Scholar
• Sunde M, Serpell LC, Bartlam M, et al. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol. 1997;273:729–739.
   PubMed Web of Science ®Google Scholar
• Chiti F, Calamai M, Taddei N, et al. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc Natl Acad Sci USA. 2002;99:16419–16426.
   PubMed Web of Science ®Google Scholar
• Lopez de la Paz M, Serrano L. Sequence determinants of amyloid fibril formation. Proc Natl Acad Sci USA. 2004;101:87–92.
   PubMed Web of Science ®Google Scholar
• Knowles TP, Waudby CA, Devlin GL, et al. An analytical solution to the kinetics of breakable filament assembly. Science. 2009;326:1533–1537.
   PubMed Web of Science ®Google Scholar
• Knowles TP, Vendruscolo M, Dobson CM. The amyloid state and its association with protein misfolding diseases. Nat Rev Mol Cell Biol. 2014;15:384–396.
   PubMed Web of Science ®Google Scholar
• Kelly JW. Mechanisms of amyloidogenesis. Nat Struct Biol. 2000;7:824–826.
   PubMedGoogle Scholar
• Castillo V, Ventura S. Amyloidogenic regions and interaction surfaces overlap in globular proteins related to conformational diseases. PLoS Comput Biol. 2009;5:e1000476.
   PubMed Web of Science ®Google Scholar
• Tsolis AC, Papandreou NC, Iconomidou VA, et al. A consensus method for the prediction of ‘aggregation-prone’ peptides in globular proteins. PLoS One. 2013;8:e54175.
   PubMed Web of Science ®Google Scholar
• Nelson R, Eisenberg D. Recent atomic models of amyloid fibril structure. Curr Opin Struct Biol. 2006;16:260–265.
   PubMed Web of Science ®Google Scholar
• Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem. 2006;75:333–366.
   PubMed Web of Science ®Google Scholar
• Apweiler R, Bairoch A, Wu CH. Protein sequence databases. Curr Opin Chem Biol. 2004;8:76–80.
   PubMed Web of Science ®Google Scholar
• Xenarios I, Eisenberg D. Protein interaction databases. Curr Opin Biotechnol. 2001;12:334–339.
   PubMed Web of Science ®Google Scholar
• Chiti F, Webster P, Taddei N, et al. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci USA. 1999;96:3590–3594.
   PubMed Web of Science ®Google Scholar
• Hamodrakas SJ. Protein aggregation and amyloid fibril formation prediction software from primary sequence: towards controlling the formation of bacterial inclusion bodies. FEBS J. 2011;278:2428–2435.
   PubMed Web of Science ®Google Scholar
• Ahmed AB, Kajava AV. Breaking the amyloidogenicity code: methods to predict amyloids from amino acid sequence. FEBS Lett. 2013;587:1089–1095.
   PubMed Web of Science ®Google Scholar
• De Baets G, Schymkowitz J, Rousseau F. Predicting aggregation-prone sequences in proteins. Essays Biochem. 2014;56:41–52.
   PubMed Web of Science ®Google Scholar
• Boutet E, Lieberherr D, Tognolli M, et al. UniProtKB/Swiss-Prot, the manually annotated section of the UniProt KnowledgeBase: how to use the entry view. Methods Mol Biol. 2016;1374:23–54.
   PubMedGoogle Scholar
• UniProt C. The Universal Protein Resource (UniProt). Nucleic Acids Res. 2007;35:D193–D197.
   PubMed Web of Science ®Google Scholar
• Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860–921.
   PubMed Web of Science ®Google Scholar
• Thompson MJ, Sievers SA, Karanicolas J, et al. The 3D profile method for identifying fibril-forming segments of proteins. Proc Natl Acad Sci USA. 2006;103:4074–4078.
   PubMed Web of Science ®Google Scholar
• Goldschmidt L, Teng PK, Riek R, et al. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc Natl Acad Sci USA. 2010;107:3487–3492.
   PubMed Web of Science ®Google Scholar
• Belli M, Ramazzotti M, Chiti F. Prediction of amyloid aggregation in vivo. EMBO Rep. 2011;12:657–663.
   PubMed Web of Science ®Google Scholar
• Tian J, Wu N, Guo J, et al. Prediction of amyloid fibril-forming segments based on a support vector machine. BMC Bioinformatics. 2009;10:S45.
   PubMed Web of Science ®Google Scholar
• Linding R, Schymkowitz J, Rousseau F, et al. A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. J Mol Biol. 2004;342:345–353.
   PubMed Web of Science ®Google Scholar
• de Groot NS, Castillo V, Grana-Montes R, et al. AGGRESCAN: method, application, and perspectives for drug design. Methods Mol Biol. 2012;819:199–220.
   PubMedGoogle Scholar
• Frousios KK, Iconomidou VA, Karletidi CM, et al. Amyloidogenic determinants are usually not buried. BMC Struct Biol. 2009;9:44.
   PubMed Web of Science ®Google Scholar
• Citron M, Oltersdorf T, Haass C, et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature. 1992;360:672–674.
   PubMed Web of Science ®Google Scholar
• Siepen JA, Westhead DR. The fibril_one on-line database: mutations, experimental conditions, and trends associated with amyloid fibril formation. Protein Sci. 2002;11:1862–1866.
   PubMed Web of Science ®Google Scholar
• Sawaya MR, Sambashivan S, Nelson R, et al. Atomic structures of amyloid cross-beta spines reveal varied steric zippers. Nature. 2007;447:453–457.
   PubMed Web of Science ®Google Scholar
• Pawlicki S, Le Bechec A, Delamarche C. AMYPdb: a database dedicated to amyloid precursor proteins. BMC Bioinformatics. 2008;9:273.
   PubMed Web of Science ®Google Scholar
• Sigrist CJ, Cerutti L, Hulo N, et al. PROSITE: a documented database using patterns and profiles as motif descriptors. Brief Bioinformatics. 2002;3:265–274.
   PubMedGoogle Scholar
• Smaoui MR, Poitevin F, Delarue M, et al. Computational assembly of polymorphic amyloid fibrils reveals stable aggregates. Biophys J. 2013;104:683–693.
   PubMed Web of Science ®Google Scholar
• Teng PK, Eisenberg D. Short protein segments can drive a non-fibrillizing protein into the amyloid state. Protein Eng Des Sel. 2009;22:531–536.
   PubMed Web of Science ®Google Scholar
• Tsiolaki PL, Louros NN, Hamodrakas SJ, et al. Exploring the 'aggregation-prone' core of human Cystatin C: a structural study. J Struct Biol. 2015;191:272–280.
   PubMed Web of Science ®Google Scholar
• Louros NN, Tsiolaki PL, Zompra AA, et al. Structural studies and cytotoxicity assays of 'aggregation-prone' IAPP(8-16) and its non-amyloidogenic variants suggest its important role in fibrillogenesis and cytotoxicity of human amylin. Biopolymers. 2015;104:196–205.
   PubMed Web of Science ®Google Scholar
• Louros NN, Tsiolaki PL, Griffin MD, et al. Chameleon 'aggregation-prone' segments of apoA-I: a model of amyloid fibrils formed in apoA-I amyloidosis. Int J Biol Macromol. 2015;79:711–718.
   PubMed Web of Science ®Google Scholar
• Tsiolaki PL, Hamodrakas SJ, Iconomidou VA. The pentapeptide LQVVR plays a pivotal role in human cystatin C fibrillization. FEBS Lett. 2015;589:159–164.
   PubMed Web of Science ®Google Scholar
• Trainor K, Broom A, Meiering EM. Exploring the relationships between protein sequence, structure and solubility. Curr Opin Struct Biol. 2017;42:136–146.
   PubMed Web of Science ®Google Scholar
• Beerten J, Van Durme J, Gallardo R, et al. WALTZ-DB: a benchmark database of amyloidogenic hexapeptides. Bioinformatics. 2015;31:1698–1700.
   PubMed Web of Science ®Google Scholar
• Maurer-Stroh S, Debulpaep M, Kuemmerer N, et al. Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat Meth. 2010;7:237–242.
   PubMed Web of Science ®Google Scholar
• Eisenberg D, Jucker M. The amyloid state of proteins in human diseases. Cell. 2012;148:1188–1203.
   PubMed Web of Science ®Google Scholar
• Thangakani AM, Nagarajan R, Kumar S, et al. CPAD, curated protein aggregation database: a repository of manually curated experimental data on protein and peptide aggregation. PLoS One. 2016;11:e0152949.
   PubMed Web of Science ®Google Scholar
• Rose PW, Prlic A, Altunkaya A, et al. The RCSB protein data bank: integrative view of protein, gene and 3D structural information. Nucleic Acids Res. 2017;45:D271–D281.
   PubMed Web of Science ®Google Scholar
• Wozniak PP, Kotulska M. AmyLoad: website dedicated to amyloidogenic protein fragments. Bioinformatics. 2015;31:3395–3397.
   PubMed Web of Science ®Google Scholar
• Conchillo-Sole O, de Groot NS, Aviles FX, et al. AGGRESCAN: a server for the prediction and evaluation of “hot spots” of aggregation in polypeptides. BMC Bioinformatics. 2007;8:65.
   PubMed Web of Science ®Google Scholar
• Fernandez-Escamilla AM, Rousseau F, Schymkowitz J, et al. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol. 2004;22:1302–1306.
   PubMed Web of Science ®Google Scholar
• Pepys MB. Amyloidosis. Annu Rev Med. 2006;57:223–241.
   PubMed Web of Science ®Google Scholar
• Rowczenio DM, Noor I, Gillmore JD, et al. Online registry for mutations in hereditary amyloidosis including nomenclature recommendations. Hum Mutat. 2014;35:E2403–24E2412.
   PubMed Web of Science ®Google Scholar
• Wood EH. MEDLINE: the options for health professionals. J Am Med Inform Assoc. 1994;1:372–380.
   PubMed Web of Science ®Google Scholar
• Hamosh A, Scott AF, Amberger JS, et al. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 2005;33:D514–D517.
   PubMed Web of Science ®Google Scholar
• Sanchorawala V. Light-chain (AL) amyloidosis: diagnosis and treatment. Clin J Am Soc Nephrol. 2006;1:1331–1341.
   PubMed Web of Science ®Google Scholar
• Bodi K, Prokaeva T, Spencer B, et al. AL-Base: a visual platform analysis tool for the study of amyloidogenic immunoglobulin light chain sequences. Amyloid. 2009;16:1–8.
   PubMed Web of Science ®Google Scholar
• Bertram L, McQueen MB, Mullin K, et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet. 2007;39:17–23.
   PubMed Web of Science ®Google Scholar
• Lill CM, Roehr JT, McQueen MB, et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database. PLoS Genet. 2012;8:e1002548.
   PubMed Web of Science ®Google Scholar
• Yang JO, Kim WY, Jeong SY, et al. PDbase: a database of Parkinson's disease-related genes and genetic variation using substantia nigra ESTs. BMC Genomics. 2009;10:S32.
   PubMedGoogle Scholar
• Cruts M, Theuns J, Van Broeckhoven C. Locus-specific mutation databases for neurodegenerative brain diseases. Hum Mutat. 2012;33:1340–1344.
   PubMed Web of Science ®Google Scholar
• Shobana R, Pandaranayaka EP. ProADD: a database on protein aggregation diseases. Bioinformation. 2014;10:390–392.
   PubMedGoogle Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–2504.
   PubMed Web of Science ®Google Scholar
• Allen NC, Bagade S, McQueen MB, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet. 2008;40:827–834.
   PubMed Web of Science ®Google Scholar
• Buchel F, Rodriguez N, Swainston N, et al. Path2Models: large-scale generation of computational models from biochemical pathway maps. BMC Syst Biol. 2013;7:116
   PubMed Web of Science ®Google Scholar
• Benson DA, Karsch-Mizrachi I, Lipman DJ, et al. GenBank. Nucleic Acids Res. 2000;28:15–18.
   PubMed Web of Science ®Google Scholar
• Larkin MA, Blackshields G, Brown NP, et al. Clustal W and Clustal X version 2.0. Bioinformatics. 2007;23:2947–2948.
   PubMed Web of Science ®Google Scholar
• Rost B. Review: protein secondary structure prediction continues to rise. J Struct Biol. 2001;134:204–218.
   PubMed Web of Science ®Google Scholar
• Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 1983;22:2577–2637.
   PubMed Web of Science ®Google Scholar
• Altschul SF, Gish W, Miller W, et al. Basic local alignment search tool. J Mol Biol. 1990;215:403–410.
   PubMed Web of Science ®Google Scholar
• Zibaee S, Makin OS, Goedert M, et al. A simple algorithm locates beta-strands in the amyloid fibril core of alpha-synuclein, Abeta, and tau using the amino acid sequence alone. Protein Sci. 2007;16:906–918.
   PubMed Web of Science ®Google Scholar
• Garbuzynskiy SO, Lobanov MY, Galzitskaya OV. FoldAmyloid: a method of prediction of amyloidogenic regions from protein sequence. Bioinformatics. 2010;26:326–332.
   PubMed Web of Science ®Google Scholar
• Walsh I, Seno F, Tosatto SC, et al. PASTA 2.0: an improved server for protein aggregation prediction. Nucleic Acids Res. 2014;42:W301–W307.
   PubMed Web of Science ®Google Scholar
• Kim C, Choi J, Lee SJ, et al. NetCSSP: web application for predicting chameleon sequences and amyloid fibril formation. Nucleic Acids Res. 2009;37:W469–W473.
   PubMed Web of Science ®Google Scholar
• Thangakani AM, Kumar S, Nagarajan R, et al. GAP: towards almost 100 percent prediction for beta-strand-mediated aggregating peptides with distinct morphologies. Bioinformatics. 2014;30:1983–1990.
   PubMed Web of Science ®Google Scholar
• Bryan AW Jr, Menke M, Cowen LJ, et al. BETASCAN: probable beta-amyloids identified by pairwise probabilistic analysis. PLoS Comput Biol. 2009;5:e1000333.
   PubMed Web of Science ®Google Scholar
• Tartaglia GG, Vendruscolo M. The Zyggregator method for predicting protein aggregation propensities. Chem Soc Rev. 2008;37:1395–1401.
   PubMed Web of Science ®Google Scholar
• Gasior P, Kotulska M. FISH Amyloid – a new method for finding amyloidogenic segments in proteins based on site specific co-occurrence of aminoacids. BMC Bioinformatics. 2014;15:54.
   PubMed Web of Science ®Google Scholar
• Lill CM, Abel O, Bertram L, et al. Keeping up with genetic discoveries in amyotrophic lateral sclerosis: the ALSoD and ALSGene databases. Amyotroph Lateral Scler. 2011;12:238–249.
   PubMed Web of Science ®Google Scholar
• Becker KG, Barnes KC, Bright TJ, et al. The genetic association database. Nat Genet. 2004;36:431–432.
   PubMed Web of Science ®Google Scholar
• Stenson PD, Ball EV, Mort M, et al. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat. 2003;21:577–581.
   PubMed Web of Science ®Google Scholar
• Keshava Prasad TS, Goel R, Kandasamy K, et al. Human Protein Reference Database—2009 update. Nucleic Acids Res. 2009;37:D767–D772.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Araki M, Goto S, et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res. 2008;36:D480–D484.
   PubMed Web of Science ®Google Scholar
• Vucetic S, Obradovic Z, Vacic V, et al. DisProt: a database of protein disorder. Bioinformatics. 2005;21:137–140.
   PubMed Web of Science ®Google Scholar